Optical Genome Mapping for a Patient with a Congenital Disorder and Chromosomal Translocation.

Breakpoint Chromosomal translocation Genomic rearrangement Optical genome mapping Whole-genome sequencing

Journal

Cytogenetic and genome research
ISSN: 1424-859X
Titre abrégé: Cytogenet Genome Res
Pays: Switzerland
ID NLM: 101142708

Informations de publication

Date de publication:
2022
Historique:
received: 19 10 2022
accepted: 11 05 2023
medline: 26 5 2023
pubmed: 26 5 2023
entrez: 26 5 2023
Statut: ppublish

Résumé

We performed optical genome mapping (OGM), a newly developed cytogenetic technique, for a patient with a disorder of sex development (DSD) and a 46,XX,t(9;11)(p22;p13) karyotype. The results of OGM were validated using other methods. OGM detected a 9;11 reciprocal translocation and successfully mapped its breakpoints to small regions of 0.9-12.3 kb. OGM identified 46 additional small structural variants, only three of which were detected by array-based comparative genomic hybridization. OGM suggested the presence of complex rearrangements on chromosome 10; however, these variants appeared to be artifacts. The 9;11 translocation was unlikely to be associated with DSD, while the pathogenicity of the other structural variants remained unknown. These results indicate that OGM is a powerful tool for detecting and characterizing chromosomal structural variations, although the current methods of OGM data analyses need to be improved.

Identifiants

pubmed: 37231804
pii: 000531103
doi: 10.1159/000531103
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

617-624

Informations de copyright

© 2023 S. Karger AG, Basel.

Auteurs

Yasuko Ogiwara (Y)

Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Department of Advanced Pediatric Medicine, Tohoku University School of Medicine, Tokyo, Japan.

Atsushi Hattori (A)

Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Division of Diversity Research, National Research Institute for Child Health and Development, Tokyo, Japan.

Kento Ikegawa (K)

Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.

Yukihiro Hasegawa (Y)

Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.

Yoko Kuroki (Y)

Division of Diversity Research, National Research Institute for Child Health and Development, Tokyo, Japan.
Department of Genome Medicine, National Research Institute for Child Health and Development, Tokyo, Japan.

Mami Miyado (M)

Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.

Maki Fukami (M)

Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Division of Diversity Research, National Research Institute for Child Health and Development, Tokyo, Japan.

Classifications MeSH